NCT00073554View on ClinicalTrials.gov

Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2003

Conditions
Arterial Occlusive DiseasesPeripheral Vascular DiseasesThrombosis
Interventions
DRUG

Alfimeprase

Trial Locations (1)

Unknown

Cleveland Clinic Foundation, Cleveland

Sponsors

Collaborators (1)

Premier Research
All Listed Sponsors
collaborator

Premier Research

OTHER

lead

ARCA Biopharma, Inc.

INDUSTRY

NCT00073554 - Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion | Biotech Hunter | Biotech Hunter